Skip to content

C50.222

Billable

Malignant neoplasm of upper-inner quadrant of left male breast

HCC Category Mapping

V28HCC 23Melanoma and Other Skin Cancers
0.251
V24HCC 12Breast, Prostate, and Other Cancers and Tumors
0.150
ESRDHCC 12Breast, Prostate, and Other Cancers and Tumors
0.000
RxHCCHCC 22Cancer, Other Specified Sites
0.000

What This Code Means

Cancer that starts in the upper-inner area of the left breast in a male patient.

Coding Tips

  • Confirm laterality documentation specifies left breast to differentiate from C50.221
  • Male breast cancer is less common than female breast cancer; ensure gender is accurately documented

Clinical Significance

Malignant neoplasm of the upper-inner quadrant of left male breast represents invasive breast cancer requiring staging, treatment planning, and ongoing surveillance. Breast cancer is risk-adjusted because it demands significant healthcare resources including surgery, radiation, chemotherapy, hormonal therapy, and long-term monitoring. Male breast cancer accounts for less than 1% of all breast cancers, making accurate gender-specific coding particularly important for tracking and research.

Documentation Requirements

  • Pathologic confirmation of invasive malignancy (biopsy with histologic type — ductal, lobular, etc.)
  • Laterality: left breast
  • Gender documented as male to support gender-specific code selection
  • Quadrant or subsite location: upper-inner quadrant
  • Tumor size (T stage) and grade
  • Lymph node status (N stage) — axillary, sentinel node biopsy results
  • Estrogen receptor, progesterone receptor, and HER2 status
  • Stage grouping (I-IV)
  • Current treatment status (active treatment, hormonal therapy, surveillance)

Commonly Confused Codes

Open C50.222 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.